MAPT and Alzheimer disease: This trend has also been seen in blood plasma [209] and cerebrospinal fluid (CSF) of AD cases [259], where CSF PSCK9 protein levels were positively correlated with AD biomarkers including Aβ, pTau, and total tau, most notably in women [232,259].